tifluadom has been researched along with levallorphan in 1 studies
| Studies (tifluadom) | Trials (tifluadom) | Recent Studies (post-2010) (tifluadom) | Studies (levallorphan) | Trials (levallorphan) | Recent Studies (post-2010) (levallorphan) |
|---|---|---|---|---|---|
| 78 | 0 | 0 | 10 | 0 | 0 |
| 78 | 0 | 0 | 413 | 13 | 12 |
| Protein | Taxonomy | tifluadom (IC50) | levallorphan (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0008 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Su, TP | 1 |
1 other study(ies) available for tifluadom and levallorphan
| Article | Year |
|---|---|
Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzodiazepines; Binding Sites; Brain; Cyclazocine; Dynorphins; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Ethylketocyclazocine; Etorphine; Guinea Pigs; Levallorphan; Peptide Fragments; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Stereoisomerism | 1985 |